Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker SUNC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 3, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 3, 2026 | SUNC SunocoCorp LLC | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 10, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 10, 2026 | SUNC SunocoCorp LLC | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 10, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 4, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 4, 2026 | SUNC SunocoCorp LLC | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 5, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 5, 2026 | SUNC SunocoCorp LLC | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 21, 2026 | SUNC SunocoCorp LLC | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 21, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 17, 2026 | SUNC SunocoCorp LLC | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 17, 2026 | SUNC SunocoCorp LLC | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 10, 2025 | SUNC SunocoCorp LLC | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Nov 3, 2025 | SUNC SunocoCorp LLC | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances